LifeBiotic

Company Overview

Snapshot

Founded in January 2009 by Dr. Yair Maimon, LifeBiotic operates with 1–10 employees. The company focuses on developing natural products for oncology support and in May 2022, its botanical formula demonstrated significant destruction of multiple GI cancer cells.

Business overview

LifeBiotic bridges the gap between nature and science in oncology support, developing natural products based on bioactive botanicals adapted from traditional herbal medicine. Its core products, including Protectival, Tonix-R, and ProtectiVet, are tested in combination with conventional treatments like chemotherapy and radiotherapy to ensure safety and efficacy without drug interactions or side effects. The company serves the healthcare and pharmaceutical sectors, targeting patients with solutions for immune support and cellular health.

Strategic signal

In May 2022, LifeBiotic's botanical formula showed significant efficacy in destroying multiple GI cancer cells. This development highlights the company's progress in validating its natural product pipeline through scientific research, signaling potential for broader clinical applications and market expansion in oncology support.

Company Intelligence Q&A

What is LifeBiotic's primary focus?

LifeBiotic focuses on developing evidence-based natural products to support oncology patients, bridging traditional herbal medicine with modern scientific validation.

When was LifeBiotic founded?

LifeBiotic was founded in January 2009.

Who is the founder of LifeBiotic?

Dr. Yair Maimon is the founder of LifeBiotic.

What significant research finding did LifeBiotic announce in May 2022?

In May 2022, LifeBiotic announced that its botanical formula demonstrated significant destruction of multiple GI cancer cells.

What is Protectival?

Protectival is a patented natural formula developed by LifeBiotic that promotes the recovery of red and white blood cells and selectively protects healthy cells while destroying damaged cells.